MSK Awards & Appointments June 2023

MSK Awards & Appointments January 2023

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:

Selwyn M. Vickers, MD, FACS, President and CEO
Selwyn Vickers Named Among 50 Most Influential Clinical Executives by Modern Healthcare

Selwyn M. Vickers, MD, FACS, President and CEO, was named one of Modern Healthcare’s 50 Most Influential Clinical Executives. The list honors licensed clinicians in executive roles who are deemed by their peers and the senior editors of Modern Healthcare to be paving the way to better health through their executive responsibility, leadership qualities, innovation, community service, and achievements inside and outside of their respective organizations.

Chrysothemis Brown, MBBS, PhD
Chrysothemis Brown Named a 2023 Pew Scholar in the Biomedical Sciences

Chrysothemis Brown, MBBS, PhD, physician-scientist, was named a 2023 Pew Scholar in the Biomedical Sciences by The Pew Charitable Trusts, which provides funding to young investigators of outstanding promise in science relevant to the advancement of human health. The program makes grants to selected academic institutions to support the independent research of outstanding early-career, junior faculty members.

Timour Baslan Wins 2023 Tri-Institutional Breakout Prize for Junior Investigators

Timour Baslan, PhD, the O’Neil Charitable Trust Fellow and postdoctoral research fellow in The Scott Lowe Lab, was awarded the 2023 Tri-Institutional Prize for Junior Investigators. Recipients of the Tri-Institutional Breakout Prize are postdoctoral trainees nominated by their mentors and selected by a committee of faculty members from MSK, Rockefeller University, and Weill Cornell Medicine. Winners are selected based on their research accomplishments, the impact of their science, and the likelihood of their success as independent investigators.

Joseph Narus Named Among Crain’s New York Business 2023 Notable LGBTQIA+ Leaders

Joseph Narus, DNP, RN, GNP-BC, ANP, Senior Director of Advanced Practice Providers, was named to the list of Crain’s New York Business 2023 Notable LGBTQIA+ Leaders. The list recognizes individuals who are driving equity and inclusion across the city’s business community. Dr. Narus leads a team of advanced practice providers and has worked on the management of sexual dysfunction after cancer treatment in the Men’s Sexual & Reproductive Medicine Program.

Publicis Foundation and MSK’s “Working with Cancer” Campaign Named Winner of Lions Health and United Nations Foundation Grand Prix for Good Award

The “Working with Cancer” campaign, won the Lions Health and United Nations Foundation Grand Pix for Good award at the Cannes Lions International Festival of Creativity. The “Working with Cancer” campaign is a cross industry coalition, driving societal progress across cultures and geographics, to end the stigma of cancer in the workplace. The award recognizes the use of creativity to positively impact not only business and brands, but also the world at large.

MSK Received 2023 Practice Greenhealth Top 25 Environmental Excellence Award

MSK’s Sustainability Program has been named one of the top 25 hospitals in the country for environmental excellence for the eighth consecutive year by Practice Greenhealth. Practice Greenhealth is the leading membership and networking organization for sustainable health care. The Environmental Excellence Awards recognize the best in healthcare environmental stewardship.

MSK Honored with the Institutional Investor Health Care System of the Year Award

MSK’s Investment Management team received the Health Care System of the Year Award by Institutional Investor at the Annual Hedge Fund Industry Awards. Institutional Investor recognizes public plans, corporate pensions, endowments, foundations, family offices, or sovereign wealth funds that have demonstrated exceptional performance innovation, achievements, and contributions to the industry in the past year.

Andri Lemarquis, MD, PhD
Andri Lemarquis Received the John Hansen Research Grant

Andri Lemarquis, MD, PhD, research scholar, received the John Hensen Research Grant by Deutsche Knochenmarkspenderdatei (DKMS). The John Hansen grant provides financial support to promising young researchers to advance the understanding of complications and therapeutic strategies in the context of hematological disease. Dr. Lemarquis was selected for his research on the role of recirculating Tregs in endogenous thymic regeneration.

Joshua A. Budhu, MD
Joshua Budhu Awarded the 2023 Jerome B. Posner Neurology Resident Teaching Award

Joshua A. Budhu, MD, MS, MPH, neurologist & neuro-oncologist, assistant attending physician, and Nicholls-Biondi Diversity Clinical Scientist Faculty Scholar, was awarded the 2023 Jerome B. Posner Neurology Resident Teaching Award for outstanding instruction of medical students, interns, and residents by The Department of Neurology at Weill Cornell Medical College.

Physicians Selected to Castle’s Connolly’s 2023 Top Asian American and Pacific Islander List

Castle Connolly recognized 23 MSK physicians on their 2023 list of Top Asian American Pacific Islander (AAPI). The new distinction is part of Castle Connolly’s Diversity Equity and Inclusion Initiative designed to honor top clinicians and enable patients to find Castle Connolly Top Doctors who have shared backgrounds and experiences.

Randy Yeh Received Inaugural Mars Shot Research Award

Randy Yeh, MD

Randy Yeh, MD, radiologist and nuclear medicine physician, was awarded the inaugural Mars Shot Research Award by The Society of Nuclear Medicine and Molecular Imaging. Dr. Yeh was selected for his proposal, “HER2, PET Imaging to Assess HER2 Heterogeneity and Predict Response to Trastuzumab-eruxtecan in HER2-low Breast Cancer. The Mars Shot Research grant recognizes individuals who have made transformative impact in the field and elevated the value of nuclear medicine and molecular imaging.

Isabelle Rivière, PhD
Isabelle Rivière Received the Jerry Mendell Award for Translational Science

Isabelle Rivière, PhD, formerly Director of the Cell Therapy and Cell Engineering Facility, was awarded the Jerry Mendell Award for Translational Science by the American Society of Gene and Cell Therapy. At MSK for more than two decades, she led a team that carried out pioneering work on engineered T lymphocytes and stem cells for the treatment of cancer and genetic blood disorders in animal models and clinical trials. The award, supported by Dr. Suku and Ann Nagendran, recognizes the extensive work required to bring gene and cell therapies to clinical trials. Dr. Rivière is no longer at MSK, but the work she was awarded for was done while she was at the institution.